Kcentra Kit
NDC Package 63833-387-02
Package Information
Kcentra (prothrombin, coagulation factor vii human, coagulation factor ix human, coagulation factor x human, protein c, protein s human, and water) kits is kcentra, (Prothrombin Complex Concentrate (Human)), is a blood coagulation factor replacement product indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with:acute major bleeding orneed for an urgent surgery/invasive procedure. This formulation utilizes a kit delivery system. Marketed by Csl Behring Gmbh, this product is identified by NDC 63833-387 and is authorized under FDA application BLA125421.
Identification & Billing
- RxCUI: 1484958 - prothrombin complex concentrate (human) 1 UNT Injection
- RxCUI: 1484958 - coagulation factor IX, human 1 UNT / coagulation factor X, human 1 UNT / factor VII, human 1 UNT / protein C, human 1 UNT / protein S, human 1 UNT / prothrombin, human 1 UNT Injection
- RxCUI: 1484958 - prothrombin complex concentrate human 1 UNT Injection
- RxCUI: 1484963 - Kcentra 1 UNT Injection
- RxCUI: 1484963 - coagulation factor IX, human 1 UNT / coagulation factor X, human 1 UNT / factor VII, human 1 UNT / protein C, human 1 UNT / protein S, human 1 UNT / prothrombin, human 1 UNT Injection [Kcentra]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63833 - Csl Behring Gmbh
- 63833-387 - Kcentra
- 63833-387-02 - 1 KIT in 1 CARTON * 40 mL in 1 VIAL, SINGLE-USE (63833-397-01) * 40 mL in 1 VIAL, SINGLE-USE (63833-761-40)
- 63833-387 - Kcentra
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63833-387-02 identifies a specific commercial package of 1 kit in 1 carton * 40 ml in 1 vial, single-use (63833-397-01) * 40 ml in 1 vial, single-use (63833-761-40) of Kcentra, a plasma derivative labeled by Csl Behring Gmbh. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Csl Behring Gmbh on December 13, 2013. The current certification is valid through December 31, 2026.
How is this Csl Behring Gmbh product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63833038702. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
